Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
25.92
-0.77 (-2.88%)
Apr 28, 2026, 2:43 PM EDT - Market open
Alamar Biosciences Revenue
In the year 2025, Alamar Biosciences had annual revenue of $74.21M with 195.17% growth.
Revenue (ttm)
$74.21M
Revenue Growth
+195.17%
P/S Ratio
23.77
Revenue / Employee
$334,284
Employees
222
Market Cap
1.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.21M | 49.07M | 195.17% |
| Dec 31, 2024 | 25.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALMR News
- 7 days ago - Alamar Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 8 days ago - Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ - PRNewsWire
- 11 days ago - Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut - Reuters
- 11 days ago - Alamar Biosciences Announces Pricing of Upsized Initial Public Offering - GLOBE NEWSWIRE
- 4 weeks ago - Protein biomarker detection platform Alamar Biosciences files for a $100 million IPO - Renaissance Capital
- 4 weeks ago - Alamar Biosciences IPO Registration Document (S-1) - SEC